The maintenance of a Buy rating by Rosenblatt suggests a positive outlook on Viavi Solutions' fundamentals or growth prospects. However, the reduction in the price target from $13 to $10 could reflect adjustments in valuation models, possibly due to revised earnings forecasts or market conditions. This mixed signal might lead to short-term uncertainty among investors, balancing the potential for both positive sentiment from the maintained Buy rating and negative sentiment from the lowered price target.